Literature DB >> 19490822

The role of FOXO in the regulation of metabolism.

Danielle N Gross1, Min Wan, Morris J Birnbaum.   

Abstract

Forkhead box O (FOXO) transcription factors play an important role in modulating metabolic functions. FOXO is regulated by several modifications, but one of the most critical is phosphorylation and nuclear exclusion by Akt. Given the impact of insulin signaling on Akt-mediated phosphorylation of FOXO and the relatively high expression of Foxo1 in insulin-responsive tissues, this transcription factor is highly poised to regulate energy metabolism. When nutrient and insulin levels are low, Foxo1 promotes expression of gluconeogenic enzymes. Conversely, in the fed state, insulin levels rise and stimulate uptake of glucose primarily into skeletal muscle and other organs, including adipose tissue. Under certain pathophysiologic conditions, including insulin resistance, negative signaling to Foxo1 is compromised. Further clarification of the role of Foxo1 in insulin-responsive tissues will strengthen our understanding and allow us to better combat insulin resistance and diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490822     DOI: 10.1007/s11892-009-0034-5

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  55 in total

1.  The forkhead transcription factor Foxo1 regulates adipocyte differentiation.

Authors:  Jun Nakae; Tadahiro Kitamura; Yukari Kitamura; William H Biggs; Karen C Arden; Domenico Accili
Journal:  Dev Cell       Date:  2003-01       Impact factor: 12.270

2.  Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake.

Authors:  Tadahiro Kitamura; Yun Feng; Yukari Ido Kitamura; Streamson C Chua; Allison W Xu; Gregory S Barsh; Luciano Rossetti; Domenico Accili
Journal:  Nat Med       Date:  2006-04-09       Impact factor: 53.440

3.  Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity.

Authors:  Diana Hoogeboom; Marieke A G Essers; Paulien E Polderman; Erik Voets; Lydia M M Smits; Boudewijn M Th Burgering
Journal:  J Biol Chem       Date:  2008-02-04       Impact factor: 5.157

4.  Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding.

Authors:  Naoto Kubota; Tetsuya Kubota; Shinsuke Itoh; Hiroki Kumagai; Hideki Kozono; Iseki Takamoto; Tomoka Mineyama; Hitomi Ogata; Kumpei Tokuyama; Mitsuru Ohsugi; Takayoshi Sasako; Masao Moroi; Kaoru Sugi; Shigeru Kakuta; Yoichiro Iwakura; Tetsuo Noda; Shin Ohnishi; Ryozo Nagai; Kazuyuki Tobe; Yasuo Terauchi; Kohjiro Ueki; Takashi Kadowaki
Journal:  Cell Metab       Date:  2008-07       Impact factor: 27.287

5.  Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis.

Authors:  Min-Seon Kim; Youngmi K Pak; Pil-Geum Jang; Cherl Namkoong; Yon-Sik Choi; Jong-Chul Won; Kyung-Sup Kim; Seung-Whan Kim; Hyo-Soo Kim; Joong-Yeol Park; Young-Bum Kim; Ki-Up Lee
Journal:  Nat Neurosci       Date:  2006-06-18       Impact factor: 24.884

6.  Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.

Authors:  Michihiro Matsumoto; Seongah Han; Tadahiro Kitamura; Domenico Accili
Journal:  J Clin Invest       Date:  2006-08-10       Impact factor: 14.808

7.  FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity.

Authors:  Michal Armoni; Chava Harel; Shiri Karni; Hui Chen; Fabiana Bar-Yoseph; Marel R Ver; Michael J Quon; Eddy Karnieli
Journal:  J Biol Chem       Date:  2006-05-02       Impact factor: 5.157

8.  Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.

Authors:  Yasutomi Kamei; Shinji Miura; Miki Suzuki; Yuko Kai; Junko Mizukami; Tomoyasu Taniguchi; Keiji Mochida; Tomoko Hata; Junichiro Matsuda; Hiroyuki Aburatani; Ichizo Nishino; Osamu Ezaki
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

9.  Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity.

Authors:  Hiroaki Daitoku; Mitsutoki Hatta; Hitomi Matsuzaki; Satoko Aratani; Takayuki Ohshima; Makoto Miyagishi; Toshihiro Nakajima; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

10.  The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.

Authors:  David S Waddell; Leslie M Baehr; Jens van den Brandt; Steven A Johnsen; Holger M Reichardt; J David Furlow; Sue C Bodine
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

View more
  87 in total

1.  Akt2: a critical regulator of cardiomyocyte survival and metabolism.

Authors:  Anthony J Muslin
Journal:  Pediatr Cardiol       Date:  2011-01-30       Impact factor: 1.655

2.  Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c.

Authors:  Min Wan; Karla F Leavens; Danish Saleh; Rachael M Easton; David A Guertin; Timothy R Peterson; Klaus H Kaestner; David M Sabatini; Morris J Birnbaum
Journal:  Cell Metab       Date:  2011-10-05       Impact factor: 27.287

Review 3.  AMP-activated protein kinase and its downstream transcriptional pathways.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

4.  Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.

Authors:  Brijesh K Singh; Rohit A Sinha; Jin Zhou; Madhulika Tripathi; Kenji Ohba; Mu-En Wang; Inna Astapova; Sujoy Ghosh; Anthony N Hollenberg; Karine Gauthier; Paul M Yen
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

5.  FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes.

Authors:  Brijesh Kumar Singh; Rohit Anthony Sinha; Jin Zhou; Sherwin Ying Xie; Seo-Hee You; Karine Gauthier; Paul Michael Yen
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

6.  Gestational-neonatal iron deficiency suppresses and iron treatment reactivates IGF signaling in developing rat hippocampus.

Authors:  Phu V Tran; Stephanie J B Fretham; Jane Wobken; Bradley S Miller; Michael K Georgieff
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-11-16       Impact factor: 4.310

7.  Wnt signaling regulates hepatic metabolism.

Authors:  Hongjun Liu; Maria M Fergusson; J Julie Wu; Ilsa I Rovira; Jie Liu; Oksana Gavrilova; Teng Lu; Jianjun Bao; Donghe Han; Michael N Sack; Toren Finkel
Journal:  Sci Signal       Date:  2011-02-01       Impact factor: 8.192

8.  Insulin effects on glucose tolerance, hypermetabolic response, and circadian-metabolic protein expression in a rat burn and disuse model.

Authors:  Heather F Pidcoke; Lisa A Baer; Xiaowu Wu; Steven E Wolf; James K Aden; Charles E Wade
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-04-23       Impact factor: 3.619

9.  FOXO transcription factors in non-alcoholic fatty liver disease.

Authors:  X Charlie Dong
Journal:  Liver Res       Date:  2017-09

Review 10.  MicroRNAs in metabolic disease.

Authors:  Carlos Fernández-Hernando; Cristina M Ramírez; Leigh Goedeke; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.